INNOVATE. CREATE. LEAD.
World changing innovations from Technion scientists have included revolutionary medical treatments, advanced cleantech solutions, breakthroughs in the field of energy, IT, engineering and much more. As the exclusive portal to the intellectual property of the academic institution voted sixth most innovative worldwide in 2013, T³ has seen dramatic year-to-year growth in patent commercialization via license agreements and establishment of new spin offs.
Technion's prized partnership with Cornell to seed a new innovation hub in New York City has demonstrated the institute's incarnation of the Start-up Nation. Today, with three active Nobel laureates in science, Technion is the motor of the Israeli high-tech industry from revolutionary research spanning the scientific spectrum from medical treatments to breakthroughs in energy, IT, clean-tech, engineering and more.
During the past years, T³ has enjoyed a robust and marked increase both in the number of patent families originating from Technion research, as well as in the number of commercialization successes. With over 600 granted patents and over 850 patents pending, T³ brings you the best in Technion know-how and research. We have put dozens of new companies on the road to success. During the past 3 years, Technion originated companies have attracted investments exceeding $150M. This too validates the value as well as the confidence of sophisticated private investor in the technologies coming out of the Technion.
Visit our strategies for commercialization section in order to review the opportunities for innovation opened by T³. We look forward to collaborate with you in the future.